Search for Clinical Trial Results

Sponsored By

Neuralgia, Postherpetic - 24 Studies Found

Status Study
Completed Study Name: Safety and Efficacy of Gabapentin in Postherpetic Neuralgia
Condition: Neuralgia,Postherpetic
Date: 2008-02-21
Interventions:
  • Drug: Gabapentin Extended Release tablets

Completed Study Name: A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)
Condition: Neuralgia, Postherpetic
Date: 2008-02-07
Interventions:
  • Drug: GEn 1200mg/day gabapenti
Completed Study Name: A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment
Condition: Neuralgia, Postherpetic
Date: 2008-02-06
Interventions:
  • Drug: GEn 1200mg/day 1200mg/da
Completed Study Name: A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)
Condition: Neuralgia, Postherpetic
Date: 2005-09-08
Interventions:
  • Drug: Placebo Daily oral dose

Completed Study Name: A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)
Condition: Neuralgia, Postherpetic
Date: 2005-09-08
Interventions: Drug: Levetiracetam
Terminated Study Name: Lamictal in the Treatment of Post-Herpetic Neuralgia
Condition: Neuralgia, Postherpetic
Date: 2006-02-22
Interventions: Drug: Lamictal in the treatment of Post-Herpetic Neuralgia
Completed Study Name: RN624 For Pain Of Post-Herpetic Neuralgia
Condition: Neuralgia, Postherpetic
Date: 2007-12-03
Interventions:
  • Drug: RN624 50 mcg/kg
Recruiting Study Name: 3VM for Treatment of Post Herpetic Neuralgia
Condition: Neuralgia, Postherpetic
Date: 2017-04-27
Interventions:
  • Drug: Experimental: 3VM1001 Cream

Completed Study Name: A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia
Condition: Neuralgia, Postherpetic
Date: 2007-01-18
Interventions: Drug: pregabalin Dosage: 150-600 mg/day (75-300 mg bid), oral administration, Treatment duration: 52 wee
Withdrawn Study Name: Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN
Condition: Neuralgia, Postherpetic
Date: 2015-04-17
Interventions:
  • Drug: EMA401 200 mg
  • Drug: EMA401 600 mg
Next >>>